Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) shares traded down 0.4% on Monday . The company traded as low as C$1.37 and last traded at C$1.37. 10,000 shares changed hands during trading, a decline of 83% from the average session volume of 60,468 shares. The stock had previously closed at C$1.38.
Genscript Biotech Stock Performance
The stock’s 50 day simple moving average is C$1.42 and its two-hundred day simple moving average is C$1.39.
About Genscript Biotech
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.
Further Reading
- Five stocks we like better than Genscript Biotech
- What is the Euro STOXX 50 Index?
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- What Are Trending Stocks? Trending Stocks Explained
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
